複選題
19. Regarding to the statements of the onco-immunology (IO), which are CORRECT?
(A) PD1/PDL1 is the immune checkpoint pathway
(B) Antibody to stimulate the PD1 has shown the therapeutic benefit for cancer patients
(C) Activation or up-regulation of PDL1 in tumor cells could inhibit the T-cell activation
(D) Lower level of PDL1 in tumor tissues might show the better outcome of patients with cancer immunotherapy (e.g., Pembrolizumab)
(E) The adverse effects of the cancer immunotherapies include interstitial pneumonitis
答案:登入後查看
統計: 尚無統計資料
統計: 尚無統計資料